May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Study of the RAX Gene in Patients With Microphthalmia/Anophthalmia/Coloboma
Author Affiliations & Notes
  • N. London
    Ophthalmology,
    Cleveland Clinic Foundation, Cleveland, OH
  • P. Kessler
    Lerner Research Institute,
    Cleveland Clinic Foundation, Cleveland, OH
  • B. Williams
    Lerner Research Institute,
    Cleveland Clinic Foundation, Cleveland, OH
  • G. Pauer
    Ophthalmic Research,
    Cleveland Clinic Foundation, Cleveland, OH
  • S. Crowe
    Ophthalmology,
    Cleveland Clinic Foundation, Cleveland, OH
  • S. Hagstrom
    Ophthalmic Research,
    Cleveland Clinic Foundation, Cleveland, OH
  • E.I. Traboulsi
    Ophthalmology,
    Cleveland Clinic Foundation, Cleveland, OH
  • Footnotes
    Commercial Relationships  N. London, None; P. Kessler, None; B. Williams, None; G. Pauer, None; S. Crowe, None; S. Hagstrom, None; E.I. Traboulsi, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1837. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. London, P. Kessler, B. Williams, G. Pauer, S. Crowe, S. Hagstrom, E.I. Traboulsi; Study of the RAX Gene in Patients With Microphthalmia/Anophthalmia/Coloboma . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1837.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Microphthalmia, anophthalmia, and coloboma (MAC) are thought to have a significant genetic component. RAX is a homeobox gene that is expressed early in the developing retina and is important in retinal cell fate specification as well as in stem cell proliferation. Voronina et al. identified a single patient who was a compound heterozygote for autosomal recessive RAX mutations within a group of 75 anophthalmia and/or microphthalmia patients (Hum Mol Genet 2004; 13:315–322). These authors also reported two polymorphisms in the first and third exons. We screened a group of 25 MAC patients for RAX mutations. Methods: We used standard PCR and automated sequencing techniques to amplify and sequence each of the three RAX exons. Patientsâ€TM charts were reviewed for clinical information. Results: In addition to the polymorphisms described by Voronina et al., we identified a prevalent single nucleotide change (106 G>A) in the first exon that results in a glutamine to lysine alteration in the primary amino acid sequence. We further identified two other single nucleotide variations, also in the first exon, in two separate patients (153 A>C and 146 G>A), each resulting in an alteration in the primary sequence. We found no apparent correlation between the observed nucleotide variations and patient phenotype. Conclusions: Sequence variations in RAX are common in our particular cohort of patients with major congenital ocular malformations and may play a role in the pathogenesis of these abnormalities.

Keywords: gene screening • infant vision • transcription factors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×